Key result
Peripheral blood macrophages reliably detected collagen VI protein defects and transcriptional abnormalities at levels comparable to muscle biopsy samples in patients with collagen VI myopathies.
Why the study?
Can peripheral blood macrophages be used to detect collagen VI alterations compared to muscle biopsy in patients with collagen VI-related myopathies?
Observational (n=5)
Can peripheral blood macrophages be used to detect collagen VI alterations compared to muscle biopsy in patients with collagen VI-related myopathies?
Peripheral blood macrophages may serve as a reliable, minimally invasive alternative to muscle or skin biopsies for diagnosing and monitoring collagen VI-related myopathies.
No takes yet. Share an insight, caveat, or question.
May support macrophage testing as a less invasive option; leaves open validation in larger cohorts before clinical adoption.
Gualandi et al. (2011) conducted an observational in Collagen VI-related myopathies (n=5). Peripheral blood macrophages testing vs. Muscle biopsy was evaluated on Detection of collagen VI alterations. Peripheral blood macrophages reliably detected collagen VI protein defects and transcriptional abnormalities at levels comparable to muscle biopsy samples in patients with collagen VI myopathies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: